Cash flow Sensus Healthcare, Inc.

Equities

SRTS

US81728J1097

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-07-11 pm EDT			5-day change	1st Jan Change
4.160 ^USD	-9.17%		-10.73%	-39.88%

May. 23	Sensus Healthcare, Inc., Q1 2025 Earnings Call, May 15, 2025
May. 15	Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	CI

6e8dbd104db76c2d0f6054a3307.Oh2EcOtt2RqlWHyogVTpJ4GlYr3kwalMwZjAV4AXgWA.CXvcPYg1oF30bAidxie9Ubn2Ac-tgMF1rfKkJchi0ihWa9xAqR-zcO41MQ

Published financial data: SENSUS HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	9.58M	27.04M	44.53M	24.4M	41.81M
Total Revenues	9.58M	27.04M	44.53M	24.4M	41.81M
Cost of Goods Sold, Total	4.33M	10.05M	14.9M	10.34M	17.38M
Gross Profit	5.25M	16.99M	29.63M	14.06M	24.43M
Selling General & Admin Expenses, Total	9.33M	9.43M	11.34M	10.76M	12.12M
R&D Expenses	4.16M	3.44M	3.46M	3.68M	4.22M
Other Operating Expenses, Total	13.48M	12.87M	14.8M	14.44M	16.34M
Operating Income	-8.23M	4.12M	14.83M	-382K	8.09M
Interest Expense, Total	-14.23K	-2K	-2K	-	-
Interest And Investment Income	66.78K	2K	382K	992K	932K
Net Interest Expenses	52.56K	0	380K	992K	932K
EBT, Excl. Unusual Items	-8.18M	4.12M	15.21M	610K	9.02M
Gain (Loss) On Sale Of Assets	-	-1K	12.78M	42K	-
Other Unusual Items	1.35M	-	-	-	-
EBT, Incl. Unusual Items	-6.84M	4.12M	27.99M	652K	9.02M
Income Tax Expense	-	-	3.75M	167K	2.38M
Earnings From Continuing Operations	-6.84M	4.12M	24.24M	485K	6.65M
Net Income to Company	-6.84M	4.12M	24.24M	485K	6.65M
Net Income - (IS)	-6.84M	4.12M	24.24M	485K	6.65M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-6.84M	4.12M	24.24M	485K	6.65M
Net Income to Common Excl. Extra Items	-6.84M	4.12M	24.24M	485K	6.65M
Per Share Items
Net EPS - Basic	-0.42	0.25	1.47	0.03	0.41
Basic EPS - Continuing Operations	-0.42	0.25	1.47	0.03	0.41
Basic Weighted Average Shares Outstanding	16.43M	16.48M	16.48M	16.26M	16.31M
Net EPS - Diluted	-0.42	0.25	1.46	0.03	0.41
Diluted EPS - Continuing Operations	-0.42	0.25	1.46	0.03	0.41
Diluted Weighted Average Shares Outstanding	16.43M	16.5M	16.62M	16.27M	16.36M
Normalized Basic EPS	-0.31	0.16	0.58	0.02	0.35
Normalized Diluted EPS	-0.31	0.16	0.57	0.02	0.34
Supplemental Items
EBITDA	-7.51M	4.73M	15.15M	-107K	8.33M
EBITA	-8.13M	4.22M	14.93M	-382K	8.09M
EBIT	-8.23M	4.12M	14.83M	-382K	8.09M
EBITDAR	-7.14M	5.07M	15.4M	121K	8.53M
Effective Tax Rate - (Ratio)	-	-	13.38	25.61	26.32
Current Domestic Taxes	-	-	5.46M	594K	2.43M
Total Current Taxes	-	-	5.46M	594K	2.43M
Deferred Domestic Taxes	-	-	-	-427K	-57K
Total Deferred Taxes	-	-	-1.71M	-427K	-57K
Normalized Net Income	-5.11M	2.58M	9.51M	381K	5.64M
Interest on Long-Term Debt	14.23K	2K	2K	-	-
Supplemental Operating Expense Items
Advertising Expense	515K	460K	871K	1.2M	1.2M
Selling and Marketing Expenses	5.34M	4.84M	6.33M	5.61M	4.98M
General and Administrative Expenses	3.99M	4.59M	5.01M	5.16M	7.15M
Research And Development Expense From Footnotes	4.16M	3.44M	3.46M	3.68M	4.22M
Net Rental Expense, Total	373K	335K	255K	228K	200K
Imputed Operating Lease Interest Expense	30.25K	6.67K	6.55K	-	-
Imputed Operating Lease Depreciation	343K	328K	248K	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	386K	415K	187K	328K	323K
Total Stock-Based Compensation	386K	415K	187K	328K	323K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	14.91M	14.52M	25.52M	23.15M	22.06M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	14.91M	14.52M	25.52M	23.15M	22.06M
Accounts Receivable, Total	3.78M	12.13M	17.3M	10.64M	19.73M
Total Receivables	3.78M	12.13M	17.3M	10.64M	19.73M
Inventory	4.43M	1.76M	9.84M	14.85M	13.44M
Prepaid Expenses	2.06M	2.84M	46K	-	-
Other Current Assets, Total	-	-	538K	888K	1.51M
Total Current Assets	25.17M	31.24M	53.24M	49.53M	56.74M
Gross Property Plant And Equipment	4.3M	2.98M	3.37M	3.12M	4.7M
Accumulated Depreciation	-1.86M	-2.21M	-2.13M	-1.88M	-2.12M
Net Property Plant And Equipment	2.43M	774K	1.24M	1.24M	2.58M
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	338K	146K	50K	-	-
Deferred Tax Assets Long-Term	-	-	1.71M	2.14M	2.2M
Other Long-Term Assets, Total	69.39K	75K	492K	804K	652K
Total Assets	28.01M	32.24M	56.74M	53.71M	62.16M
Liabilities
Accounts Payable, Total	2.87M	4.06M	5.52M	2.79M	4.81M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	51K	-	-	-
Current Portion of Leases	303K	174K	190K	187K	204K
Current Income Taxes Payable	-	-	890K	37K	-
Unearned Revenue Current, Total	1.49M	1.17M	693K	657K	541K
Other Current Liabilities	187K	508K	403K	538K	329K
Total Current Liabilities	4.86M	5.96M	7.7M	4.21M	5.88M
Long-Term Debt	267K	-	-	-	-
Long-Term Leases	812K	-	830K	596K	398K
Unearned Revenue Non Current	579K	262K	139K	60K	55K
Total Liabilities	6.51M	6.22M	8.67M	4.87M	6.34M
Common Stock, Total	166K	167K	169K	169K	169K
Additional Paid In Capital	43.7M	44.12M	45.03M	45.4M	45.8M
Retained Earnings	-22.06M	-17.94M	6.3M	6.79M	13.43M
Treasury Stock	-310K	-325K	-3.43M	-3.52M	-3.57M
Total Common Equity	21.5M	26.02M	48.07M	48.84M	55.83M
Total Equity	21.5M	26.02M	48.07M	48.84M	55.83M
Total Liabilities And Equity	28.01M	32.24M	56.74M	53.71M	62.16M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16.49M	16.66M	16.4M	16.39M	16.5M
ECS Total Common Shares Outstanding	16.49M	16.62M	16.39M	16.37M	16.5M
Book Value / Share	1.3	1.57	2.93	2.98	3.38
Tangible Book Value	21.16M	25.87M	48.02M	48.84M	55.83M
Tangible Book Value Per Share	1.28	1.56	2.93	2.98	3.38
Total Debt	1.38M	225K	1.02M	783K	602K
Net Debt	-13.52M	-14.29M	-24.5M	-22.36M	-21.45M
Debt Equivalent Oper. Leases	2.98M	2.68M	2.04M	1.82M	1.6M
Account Code - Inventory Valuation	5	5	5	5	5
Machinery, Total	3.22M	2.82M	2.37M	2.35M	3.89M
Full Time Employees	42	37	42	35	54
Accumulated Allowance for Doubtful Accounts (Supple)	24K	69K	107K	-	100K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-6.84M	4.12M	24.24M	485K	6.65M
Depreciation & Amortization - CF	614K	509K	219K	461K	432K
Amortization of Goodwill and Intangible Assets - (CF)	108K	104K	96K	-	-
Depreciation & Amortization, Total	722K	613K	315K	461K	432K
(Gain) Loss From Sale Of Asset	-	47K	-12.58M	-42K	-
Asset Writedown & Restructuring Costs	-	88K	-	-	-
Stock-Based Compensation (CF)	386K	415K	187K	328K	323K
Provision and Write-off of Bad Debts	24K	78K	145K	7K	123K
Other Operating Activities, Total	-292K	492K	-991K	176K	198K
Change In Accounts Receivable	10.25M	-8.43M	-5.31M	6.65M	-9.21M
Change In Inventories	-1.43M	2.74M	-3.19M	-5.3M	-93K
Change In Accounts Payable	-2.3M	962K	799K	-2.73M	2.02M
Change in Unearned Revenues	-460K	-637K	-602K	-115K	-121K
Change In Income Taxes	-	-	890K	-853K	-37K
Change in Other Net Operating Assets	-496K	-766K	-5.31M	-1.21M	-1.11M
Cash from Operations	-434K	-286K	-1.41M	-2.14M	-831K
Capital Expenditure	-359K	-128K	-159K	-229K	-276K
Sale of Property, Plant, and Equipment	-	257K	15M	42K	-
Investment in Marketable and Equity Securities, Total	7.39M	-	-	-	-
Cash from Investing	7.03M	129K	14.84M	-187K	-276K
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	267K	-	-	-	-
Total Debt Issued	267K	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-216K	-51K	-	-
Total Debt Repaid	-	-216K	-51K	-	-
Issuance of Common Stock	560	-	731K	46K	67K
Repurchase of Common Stock	-57.33K	-15K	-3.11M	-86K	-52K
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	210K	-231K	-2.43M	-40K	15K
Net Change in Cash	6.81M	-388K	11M	-2.37M	-1.09M
Supplemental Items
Cash Interest Paid	12.46K	2K	2K	-	-
Cash Income Tax Paid (Refund)	-	-	4.57M	1.44M	2.58M
Levered Free Cash Flow	2.24M	-1.8M	385K	-1.82M	-1.11M
Unlevered Free Cash Flow	2.25M	-1.8M	386K	-1.82M	-1.11M
Change In Net Working Capital	-6.64M	5.28M	9.23M	2.14M	6.65M
Net Debt Issued / Repaid	267K	-216K	-51K	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-15.85	8.55	20.84	-0.43	8.73
Return on Total Capital	-19.68	10.48	24.61	-0.48	9.54
Return On Equity %	-27.62	17.34	65.45	1	12.7
Return on Common Equity	-27.62	17.34	65.45	1	12.7
Margin Analysis
Gross Profit Margin %	54.81	62.82	66.53	57.61	58.44
SG&A Margin	97.37	34.88	25.46	44.11	29
EBITDA Margin %	-78.44	17.5	34.01	-0.44	19.92
EBITA Margin %	-84.85	15.62	33.52	-1.57	19.35
EBIT Margin %	-85.98	15.24	33.3	-1.57	19.35
Income From Continuing Operations Margin %	-71.37	15.23	54.44	1.99	15.9
Net Income Margin %	-71.37	15.23	54.44	1.99	15.9
Net Avail. For Common Margin %	-71.37	15.23	54.44	1.99	15.9
Normalized Net Income Margin	-53.39	9.52	21.35	1.56	13.49
Levered Free Cash Flow Margin	23.37	-6.67	0.86	-7.46	-2.66
Unlevered Free Cash Flow Margin	23.46	-6.66	0.87	-7.46	-2.66
Asset Turnover
Asset Turnover	0.29	0.9	1	0.44	0.72
Fixed Assets Turnover	3.9	16.87	44.24	19.71	21.91
Receivables Turnover (Average Receivables)	1.08	3.4	3.03	1.75	2.75
Inventory Turnover (Average Inventory)	1.17	3.25	2.11	0.84	1.23
Short Term Liquidity
Current Ratio	5.18	5.24	6.92	11.76	9.64
Quick Ratio	3.85	4.47	5.56	8.02	7.1
Operating Cash Flow to Current Liabilities	-0.09	-0.05	-0.18	-0.51	-0.14
Days Sales Outstanding (Average Receivables)	339.88	107.35	120.61	208.96	132.96
Days Outstanding Inventory (Average Inventory)	313.93	112.29	172.97	434.14	297.95
Average Days Payable Outstanding	243.24	171.28	85.47	98.33	87.12
Cash Conversion Cycle (Average Days)	410.57	48.35	208.11	544.77	343.8
Long Term Solvency
Total Debt/Equity	6.43	0.86	2.12	1.6	1.08
Total Debt / Total Capital	6.04	0.86	2.08	1.58	1.07
LT Debt/Equity	5.02	-	1.73	1.22	0.71
Long-Term Debt / Total Capital	4.72	-	1.69	1.2	0.71
Total Liabilities / Total Assets	23.26	19.31	15.27	9.06	10.2
EBIT / Interest Expense	-578.63	2.06K	7.42K	-	-
EBITDA / Interest Expense	-501.69	2.53K	7.7K	-	-
(EBITDA - Capex) / Interest Expense	-526.88	2.47K	7.62K	-	-
Total Debt / EBITDA	-0.19	0.04	0.07	6.47	0.07
Net Debt / EBITDA	1.89	-2.82	-1.59	-184.83	-2.52
Total Debt / (EBITDA - Capex)	-0.18	0.05	0.07	-7.25	0.07
Net Debt / (EBITDA - Capex)	1.8	-2.89	-1.61	207.08	-2.6
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-64.87	182.36	64.68	-45.2	71.3
Gross Profit, 1 Yr. Growth %	-70.1	223.64	74.41	-52.54	73.76
EBITDA, 1 Yr. Growth %	428.06	-163.01	220.01	-100.71	-7.88K
EBITA, 1 Yr. Growth %	334.01	-151.98	253.39	-102.58	-2.22K
EBIT, 1 Yr. Growth %	318.33	-150.04	259.98	-102.58	-2.22K
Earnings From Cont. Operations, 1 Yr. Growth %	302.09	-160.25	488.59	-98	1.27K
Net Income, 1 Yr. Growth %	302.09	-160.25	488.59	-98	1.27K
Normalized Net Income, 1 Yr. Growth %	381.25	-150.35	269.2	-95.99	1.38K
Diluted EPS Before Extra, 1 Yr. Growth %	297.17	-159.52	484	-97.96	1.27K
Accounts Receivable, 1 Yr. Growth %	-73.05	221.24	42.61	-38.46	85.35
Inventory, 1 Yr. Growth %	47.71	-60.27	129.43	52.09	-9.45
Net Property, Plant and Equip., 1 Yr. Growth %	-2.05	-68.17	60.08	-0.08	108.24
Total Assets, 1 Yr. Growth %	-24.14	15.1	75.98	-5.33	15.74
Tangible Book Value, 1 Yr. Growth %	-23.52	22.27	85.62	1.61	14.3
Common Equity, 1 Yr. Growth %	-23.23	21.02	84.77	1.61	14.3
Cash From Operations, 1 Yr. Growth %	-79.39	-34.1	393.71	51.91	-61.26
Capital Expenditures, 1 Yr. Growth %	-10.5	-64.35	24.22	44.03	20.52
Levered Free Cash Flow, 1 Yr. Growth %	-196.57	-180.59	-121.36	-413.55	-38.96
Unlevered Free Cash Flow, 1 Yr. Growth %	-196.95	-180.22	-121.44	-413.55	-38.96
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-39.8	-0.41	115.64	-5	-3.11
Gross Profit, 2 Yr. CAGR %	-44.29	-1.63	137.58	-9.03	-9.19
EBITDA, 2 Yr. CAGR %	136.14	82.4	41.99	-84.96	-25.84
EBITA, 2 Yr. CAGR %	106.3	50.2	35.53	-69.93	-26.14
EBIT, 2 Yr. CAGR %	102.63	44.68	34.21	-69.55	-26.14
Earnings From Cont. Operations, 2 Yr. CAGR %	83.83	55.66	88.32	-65.69	-47.64
Net Income, 2 Yr. CAGR %	83.83	55.66	88.32	-65.69	-47.64
Normalized Net Income, 2 Yr. CAGR %	101.11	55.68	36.35	-61.52	-22.99
Diluted EPS Before Extra, 2 Yr. CAGR %	70.37	54.5	86.45	-65.46	-47.17
Accounts Receivable, 2 Yr. CAGR %	-46.41	-6.96	114.04	-6.32	6.8
Inventory, 2 Yr. CAGR %	64.86	-23.39	49.07	86.08	17.35
Net Property, Plant and Equip., 2 Yr. CAGR %	65.19	-44.16	-28.62	26.47	44.25
Total Assets, 2 Yr. CAGR %	-8.22	-6.56	42.32	29.07	4.68
Tangible Book Value, 2 Yr. CAGR %	-9.84	-3.3	50.65	37.41	7.77
Common Equity, 2 Yr. CAGR %	-9.87	-3.61	49.54	37.02	7.77
Cash From Operations, 2 Yr. CAGR %	-77.48	-63.15	80.37	173.86	-23.28
Capital Expenditures, 2 Yr. CAGR %	-35.24	-43.47	-33.45	33.76	31.75
Levered Free Cash Flow, 2 Yr. CAGR %	-50.78	-11.79	-58.51	0.46	38.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	-50.42	-11.82	-58.53	0.49	38.34
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-22.52	0.77	17.77	36.59	15.63
Gross Profit, 3 Yr. CAGR %	-27.54	0.15	19.06	38.88	12.88
EBITDA, 3 Yr. CAGR %	31.16	52.02	119.99	-75.76	20.73
EBITA, 3 Yr. CAGR %	30.92	30.3	99.77	-63.91	24.19
EBIT, 3 Yr. CAGR %	30.35	27.13	96.05	-64.07	25.22
Earnings From Cont. Operations, 3 Yr. CAGR %	22.59	26.75	142.5	-58.6	17.29
Net Income, 3 Yr. CAGR %	22.59	26.75	142.5	-58.6	17.29
Normalized Net Income, 3 Yr. CAGR %	30.16	26.76	107.6	-57.91	29.86
Diluted EPS Before Extra, 3 Yr. CAGR %	14.06	20.38	140.68	-58.59	17.69
Accounts Receivable, 3 Yr. CAGR %	-8.68	-2.65	7.28	41.27	17.61
Inventory, 3 Yr. CAGR %	55.77	2.6	48.62	49.68	46.36
Net Property, Plant and Equip., 3 Yr. CAGR %	83.41	-4.59	-20.68	-20.15	49.34
Total Assets, 3 Yr. CAGR %	14.14	-1.02	15.39	24.24	24.47
Tangible Book Value, 3 Yr. CAGR %	23.8	-0.2	20.18	32.16	29.23
Common Equity, 3 Yr. CAGR %	22.55	-0.56	19.74	31.47	28.99
Cash From Operations, 3 Yr. CAGR %	-47.82	-67.8	-12.49	70.34	42.7
Capital Expenditures, 3 Yr. CAGR %	7.63	-46.9	-26.51	-13.92	29.19
Levered Free Cash Flow, 3 Yr. CAGR %	2.27	-41.99	-45.02	-6.66	-14.91
Unlevered Free Cash Flow, 3 Yr. CAGR %	3.12	-41.8	-44.96	-6.78	-14.9
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.39	12.8	16.68	-1.58	8.93
Gross Profit, 5 Yr. CAGR %	-4.42	11.53	16.51	-3.63	6.83
EBITDA, 5 Yr. CAGR %	140	184.18	35.39	-39.74	42.4
EBITA, 5 Yr. CAGR %	130.36	73.7	32.74	-27.52	34
EBIT, 5 Yr. CAGR %	106.13	62.54	31.88	-28.22	32.67
Earnings From Cont. Operations, 5 Yr. CAGR %	95.84	64.07	45.56	-24.84	31.35
Net Income, 5 Yr. CAGR %	95.84	64.07	45.56	-24.84	31.35
Normalized Net Income, 5 Yr. CAGR %	103.01	64.08	32.6	-21.32	39.63
Diluted EPS Before Extra, 5 Yr. CAGR %	40.51	54.06	39.1	-26.94	31.22
Accounts Receivable, 5 Yr. CAGR %	12.76	31.38	28.39	-4.13	7.09
Inventory, 5 Yr. CAGR %	34.69	6.99	53.05	55.58	35.01
Net Property, Plant and Equip., 5 Yr. CAGR %	49.95	12.3	25.75	6.8	0.76
Total Assets, 5 Yr. CAGR %	23.79	11.22	24.67	10.07	10.98
Tangible Book Value, 5 Yr. CAGR %	32.41	12.05	33.91	13.42	15.08
Common Equity, 5 Yr. CAGR %	29.41	11.24	32.7	13.04	14.8
Cash From Operations, 5 Yr. CAGR %	-20.17	-19.59	-14.31	-24.19	-16.98
Capital Expenditures, 5 Yr. CAGR %	12.82	-14.85	-11.18	-23.16	-7.18
Levered Free Cash Flow, 5 Yr. CAGR %	10.49	17.56	-28.72	-27.74	-13.68
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.76	17.95	-28.37	-27.59	-13.68